Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management

UPDATED: Sobi bets $250M cash, about $1B in milestones for rights to a C3 therapy being pushed through 5 pivotal trials

End Points, 27 Oct 2020

Nicole DeFeudis Associate Editor A cou­ple years af­ter li­cens­ing Novim­mune’s ema­palum­ab and turn­ing around a quick FDA OK…